For the Inventor, By the Inventor

Enter inventor name

Tarrytown, NY, United States of America

Ka-Man Venus Lai

USPTO Granted Patents = 54 (Patent Applications = 24)

CIPO Patents = 9 (Patent Applications = 11)

EPO Patents = 25 (Patent Applications = 34)

Average Co-Inventor Count = 5.1

ph-index = 9

Forward Citations = 292(Granted Patents)

Forward Citations (Not Self Cited) = 158(Oct 12, 2025)

Inventors with similar research interests:

Location History:

Tarrytown, NY (US) (2013 - 2021)
San Francisco, CA (US) (2019 - 2022)
Seattle, WA (US) (2020 - 2024)

Company Filing History:

50 out of 1,342

Regeneron Pharmaceuticals, Inc.

Regeneran Pharmaceuticals, Inc.

Harvard College

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Loading Chart...

Loading Chart...

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12419282 - Non-human animals expressing humanized CD3 complex (2025-09-23),

2. 12369570 - Humanized IL-15 animals (2025-07-29),

3. 12342801 - Methods for producing antigen-binding proteins against foreign antigens (2025-07-01),

4. 12089575 - Genetically modified mouse that expresses humanized PD1 and PD-L1 proteins (2024-09-17),

5. 12065661 - Genetic modification of rats (2024-08-20),

6. 12037596 - Targeted modification of rat genome (2024-07-16),

7. 11937587 - Non-human animals expressing humanized CD3 complex (2024-03-26),

8. 11932859 - Nuclease-mediated DNA assembly (2024-03-19),

9. 11820997 - Methods and compositions for the targeted modification of a genome (2023-11-21),

10. 11730150 - Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy (2023-08-22),

11. 11697828 - Methods and compositions for targeted genetic modification using paired guide RNAs (2023-07-11),

12. 11684050 - Non-human animals having a humanized programmed cell death 1 gene (2023-06-27),

13. 11589562 - Mouse model of DITRA disease and uses thereof (2023-02-28),

14. 11547101 - Non-human animals having a disruption in a C9ORF72 locus (2023-01-10),

15. 11547100 - Method for screening gene expression in lincRNA-deficient mice or rats (2023-01-10),

Sure, I can help with that. Let's start with the article structure. Here's what we'll cover:

Title: The Innovative Work of Inventor Ka-Man Venus Lai

Introduction: Brief overview of Ka-Man Venus Lai and his contributions

Latest Patents: Description of his two latest patents

Career Highlights: Summary of his work at Regeneron Pharmaceuticals, Inc.

Collaborations: Mention of his coworkers David M. Valenzuela and David Frendewey

Conclusion: Wrap up his achievements and impact

Let's begin with the content for each section. Shall we proceed with the article?

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…